Titre : Relations interprofessionnelles

Relations interprofessionnelles : Questions médicales fréquentes

Termes MeSH sélectionnés :

Scleroderma, Localized
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Relations interprofessionnelles : Questions médicales les plus fréquentes", "headline": "Relations interprofessionnelles : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Relations interprofessionnelles : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-06", "dateModified": "2025-04-01", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Relations interprofessionnelles" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Relations interpersonnelles", "url": "https://questionsmedicales.fr/mesh/D007398", "about": { "@type": "MedicalCondition", "name": "Relations interpersonnelles", "code": { "@type": "MedicalCode", "code": "D007398", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.829.401" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Relations médecin-infirmier", "alternateName": "Physician-Nurse Relations", "url": "https://questionsmedicales.fr/mesh/D019555", "about": { "@type": "MedicalCondition", "name": "Relations médecin-infirmier", "code": { "@type": "MedicalCode", "code": "D019555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "F01.829.401.205.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Relations interprofessionnelles", "alternateName": "Interprofessional Relations", "code": { "@type": "MedicalCode", "code": "D007400", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Fatemeh Keshmiri", "url": "https://questionsmedicales.fr/author/Fatemeh%20Keshmiri", "affiliation": { "@type": "Organization", "name": "Associate Professor, Medical Education Department, Education Development Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran." } }, { "@type": "Person", "name": "Erin Abu-Rish Blakeney", "url": "https://questionsmedicales.fr/author/Erin%20Abu-Rish%20Blakeney", "affiliation": { "@type": "Organization", "name": "School of Nursing, University of Washington , Seattle , WA , USA." } }, { "@type": "Person", "name": "Azam Hosseinpour", "url": "https://questionsmedicales.fr/author/Azam%20Hosseinpour", "affiliation": { "@type": "Organization", "name": "Instructor, Department of Operating Room, School of Allied Medical Sciences, Qom University of Medical Sciences, Qom, Iran." } }, { "@type": "Person", "name": "Katja Krug", "url": "https://questionsmedicales.fr/author/Katja%20Krug", "affiliation": { "@type": "Organization", "name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. katja.krug@med.uni-heidelberg.de." } }, { "@type": "Person", "name": "Michel Wensing", "url": "https://questionsmedicales.fr/author/Michel%20Wensing", "affiliation": { "@type": "Organization", "name": "Department of General Practice and Health Services Research, Heidelberg University Hospital, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A Case of Linear Scleroderma in a Young Child: A Diagnosis Easily Missed in Primary Care.", "datePublished": "2023-05-19", "url": "https://questionsmedicales.fr/article/37202915", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.12659/AJCR.940148" } }, { "@type": "ScholarlyArticle", "name": "Atypical emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia: a case report.", "datePublished": "2022-08-19", "url": "https://questionsmedicales.fr/article/36415340", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.11604/pamj.2022.42.295.29442" } }, { "@type": "ScholarlyArticle", "name": "Skin fibrosis associated with keloid, scleroderma and Jorge Lobo's disease (lacaziosis): An immuno-histochemical study.", "datePublished": "2022-10-01", "url": "https://questionsmedicales.fr/article/36183172", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/iep.12456" } }, { "@type": "ScholarlyArticle", "name": "Systemic sclerosis following COVID-19 infection with recurrent corticosteroid-induced scleroderma renal crisis.", "datePublished": "2023-03-17", "url": "https://questionsmedicales.fr/article/36931690", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bcr-2022-253735" } }, { "@type": "ScholarlyArticle", "name": "UVA1 irradiation attenuates collagen production via Ficz/AhR/MAPK signaling activation in scleroderma.", "datePublished": "2023-01-25", "url": "https://questionsmedicales.fr/article/36706594", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.intimp.2023.109764" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Comportement et mécanismes comportementaux", "item": "https://questionsmedicales.fr/mesh/D001520" }, { "@type": "ListItem", "position": 3, "name": "Relations interpersonnelles", "item": "https://questionsmedicales.fr/mesh/D007398" }, { "@type": "ListItem", "position": 4, "name": "Relations interprofessionnelles", "item": "https://questionsmedicales.fr/mesh/D007400" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Relations interprofessionnelles - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Relations interprofessionnelles", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Relations interprofessionnelles", "description": "Comment évaluer la communication interprofessionnelle ?\nQuels indicateurs mesurent la collaboration interprofessionnelle ?\nQuels outils facilitent le diagnostic interprofessionnel ?\nComment identifier les barrières à la collaboration ?\nQuel rôle joue la culture organisationnelle dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Relations interprofessionnelles", "description": "Quels symptômes indiquent une mauvaise communication ?\nComment reconnaître un manque de collaboration ?\nQuels symptômes affectent la dynamique d'équipe ?\nQuels signes montrent une bonne collaboration ?\nComment les symptômes de stress impactent-ils les relations ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Relations interprofessionnelles", "description": "Comment prévenir les conflits interprofessionnels ?\nQuelles stratégies améliorent la prévention des erreurs ?\nComment sensibiliser à l'importance de la collaboration ?\nQuels outils aident à la prévention des erreurs médicales ?\nComment la prévention impacte-t-elle les soins ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Relations interprofessionnelles", "description": "Comment améliorer les traitements par la collaboration ?\nQuels traitements favorisent la communication ?\nComment évaluer l'efficacité des traitements interprofessionnels ?\nQuels traitements sont adaptés aux équipes interprofessionnelles ?\nComment les traitements peuvent-ils être personnalisés ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Relations interprofessionnelles", "description": "Quelles complications résultent d'une mauvaise communication ?\nComment les conflits affectent-ils les résultats des soins ?\nQuelles complications peuvent survenir en cas de mauvaise collaboration ?\nComment évaluer l'impact des complications sur les soins ?\nQuelles sont les conséquences d'une mauvaise dynamique d'équipe ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Relations interprofessionnelles", "description": "Quels facteurs augmentent le risque de conflits ?\nComment le stress influence-t-il les relations interprofessionnelles ?\nQuels facteurs de risque sont liés à la collaboration ?\nComment les différences de statut affectent-elles les relations ?\nQuels facteurs environnementaux influencent la collaboration ?", "url": "https://questionsmedicales.fr/mesh/D007400?mesh_terms=Scleroderma,+Localized&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment évaluer la communication interprofessionnelle ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des outils d'évaluation comme des questionnaires et des entretiens." } }, { "@type": "Question", "name": "Quels indicateurs mesurent la collaboration interprofessionnelle ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les indicateurs incluent la satisfaction des patients et l'efficacité des soins." } }, { "@type": "Question", "name": "Quels outils facilitent le diagnostic interprofessionnel ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les outils incluent des plateformes de partage d'informations et des réunions d'équipe." } }, { "@type": "Question", "name": "Comment identifier les barrières à la collaboration ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Par des enquêtes et des discussions en groupe pour recueillir des retours d'expérience." } }, { "@type": "Question", "name": "Quel rôle joue la culture organisationnelle dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une culture ouverte favorise la communication et la collaboration entre les professionnels." } }, { "@type": "Question", "name": "Quels symptômes indiquent une mauvaise communication ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs médicales fréquentes et des plaintes des patients peuvent en être des signes." } }, { "@type": "Question", "name": "Comment reconnaître un manque de collaboration ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des conflits fréquents et un manque de coordination dans les soins sont des indicateurs." } }, { "@type": "Question", "name": "Quels symptômes affectent la dynamique d'équipe ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Le stress, la frustration et le turnover élevé peuvent affecter la dynamique d'équipe." } }, { "@type": "Question", "name": "Quels signes montrent une bonne collaboration ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une communication fluide et des résultats positifs pour les patients sont des signes clés." } }, { "@type": "Question", "name": "Comment les symptômes de stress impactent-ils les relations ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut mener à des conflits et à une communication inefficace entre les professionnels." } }, { "@type": "Question", "name": "Comment prévenir les conflits interprofessionnels ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Par des formations régulières sur la communication et la gestion des conflits." } }, { "@type": "Question", "name": "Quelles stratégies améliorent la prévention des erreurs ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Mettre en place des protocoles clairs et des revues de cas régulières." } }, { "@type": "Question", "name": "Comment sensibiliser à l'importance de la collaboration ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Organiser des séminaires et des ateliers sur les bénéfices de la collaboration interprofessionnelle." } }, { "@type": "Question", "name": "Quels outils aident à la prévention des erreurs médicales ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les check-lists et les systèmes de double vérification sont des outils efficaces." } }, { "@type": "Question", "name": "Comment la prévention impacte-t-elle les soins ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne prévention réduit les erreurs et améliore la satisfaction des patients." } }, { "@type": "Question", "name": "Comment améliorer les traitements par la collaboration ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "En intégrant des équipes multidisciplinaires pour une approche globale des soins." } }, { "@type": "Question", "name": "Quels traitements favorisent la communication ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des formations en communication et des ateliers de team-building sont bénéfiques." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité des traitements interprofessionnels ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Par des études de cas et des analyses de résultats cliniques post-traitement." } }, { "@type": "Question", "name": "Quels traitements sont adaptés aux équipes interprofessionnelles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements complexes comme la gestion de la douleur nécessitent une approche collaborative." } }, { "@type": "Question", "name": "Comment les traitements peuvent-ils être personnalisés ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "En tenant compte des compétences et des expertises de chaque professionnel de santé." } }, { "@type": "Question", "name": "Quelles complications résultent d'une mauvaise communication ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des erreurs de traitement et des retards dans les soins peuvent survenir." } }, { "@type": "Question", "name": "Comment les conflits affectent-ils les résultats des soins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Les conflits peuvent mener à des soins fragmentés et à une insatisfaction des patients." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir en cas de mauvaise collaboration ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des complications médicales et des réadmissions fréquentes peuvent en résulter." } }, { "@type": "Question", "name": "Comment évaluer l'impact des complications sur les soins ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Par des analyses de données sur les résultats cliniques et la satisfaction des patients." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une mauvaise dynamique d'équipe ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise dynamique peut entraîner un turnover élevé et une baisse de la qualité des soins." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de conflits ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Des différences culturelles et des styles de communication variés peuvent augmenter les conflits." } }, { "@type": "Question", "name": "Comment le stress influence-t-il les relations interprofessionnelles ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut réduire la communication et augmenter les tensions entre les professionnels." } }, { "@type": "Question", "name": "Quels facteurs de risque sont liés à la collaboration ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Un manque de formation et des horaires de travail chargés peuvent nuire à la collaboration." } }, { "@type": "Question", "name": "Comment les différences de statut affectent-elles les relations ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les différences de statut peuvent créer des déséquilibres et des tensions dans l'équipe." } }, { "@type": "Question", "name": "Quels facteurs environnementaux influencent la collaboration ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un environnement de travail positif et des ressources adéquates favorisent la collaboration." } } ] } ] }

Sources (10000 au total)

Clinical and Molecular Findings After Autologous Stem Cell Transplantation or Cyclophosphamide for Scleroderma: Handling Missing Longitudinal Data.

Among individuals with systemic sclerosis (SSc) randomized to cyclophosphamide (CYC) (n = 34) or hematopoietic stem cell transplantation (HSCT) (n = 33), we examined longitudinal trends of clinical, p... Assuming that data were missing at random, mixed-effects regression models were used to estimate longitudinal trends for clinical measures when comparing treatment groups. Results were compared to obs... Available observed means for pulmonary function tests appeared to improve over time in both arms. However, after accounting for participant loss, forced vital capacity in HSCT recipients increased by ... Longitudinal trends estimated from 2 statistical models affirm the efficacy of HSCT over CYC in severe SSc. Failure to account for early loss of participants may distort estimated clinical trends over...

Development of Pulmonary Hypertension in Over One-Third of Patients With Th/To Antibody-Positive Scleroderma in Long-Term Follow-Up.

This study was undertaken to describe clinical manifestations in patients with Th/To antibody-positive systemic sclerosis (SSc) during long-term follow-up.... We performed a case-control study involving anti-Th/To antibody-positive patients with SSc who were newly referred to the University of Pittsburgh Medical Center and the Pittsburgh Scleroderma Center ... A total of 204 anti-Th/To antibody-positive SSc patients and 408 controls were identified. The cohort had a mean ± SD age of 52 ± 12.9 years, and 76% of individuals were women. Anti-Th/To antibody-pos... This is the largest cohort of patients with anti-Th/To antibody-positive SSc with long-term follow-up data. The very high rate (38%) and associated independent risk of anti-Th/To antibody-positive pat...

Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).

Patients with systemic sclerosis (SSc) are at increased risk of cancer, a growing cause of non-SSc-related death among these patients. We analyzed the increased cancer risk among Spanish patients with... Spanish Scleroderma Registry data were analyzed to determine the demographic characteristics of patients with SSc, and logistic regression was used to identify cancer risk factors. SIRs with 95% confi... Of 1930 patients with SSc, 206 had cancer, most commonly breast, lung, hematological, and colorectal cancers. Patients with SSc had increased risks of overall cancer (SIR 1.48, 95% CI 1.36-1.60; P < 0... Spanish patients with SSc had an increased cancer risk compared with the general population. Some characteristics, including specific autoantibodies, may be related to this increased risk....

Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized scleroderma Total Severity Scale (LoTSS).

Juvenile localized scleroderma (jLS) is a chronic autoimmune disease commonly associated with poor outcome, including contractures, hemi-atrophy, uveitis, and seizures. Despite improvements in treatme... LoTSS was developed as a weighted measure by a consensus process involving literature review, surveys, case vignettes, and multi-criteria decision analysis. Feasibility was assessed in larger Childhoo... LoTSS severity items were organized into modules that reflect jLS disease patterns, with modules for skin, extracutaneous, and craniofacial manifestations. Construct validity of LoTSS was supported by... We developed a new LS measure for assessing cutaneous and extracutaneous severity, and have shown it to be reliable, valid, and responsive. LoTSS is the first measure that assesses and scores all the ...